ArticleMedical oncology (Northwood, London, England)2021

Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line.

Ertan Kanbur et al.PubMed ↗Publisher ↗

No numbers read from the abstract.